OrbusNeich Medical Group Holdings (FRA:Q8T) ROIC %: 18.97% (As of Dec. 2025)


FRA:Q8T OrbusNeich Medical Group Holdings Ltd FRA:Q8T
96 GF Score
Price €0.37
GF Value €0.47
! 2 Warning Signs
View Full Analysis

What is OrbusNeich Medical Group Holdings ROIC %?

OrbusNeich Medical Group Holdings FRA:Q8T 96 ROIC % is 18.97% as of Dec. 2025. GuruFocus rates FRA:Q8T with a GF Score™ of 96/100 and a GF Value™ of €0.47. The stock has 2 warning signs investors should review.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. OrbusNeich Medical Group Holdings's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2025 was 18.97%.

As of today (2026-07-03), OrbusNeich Medical Group Holdings's WACC % is 8.85%. OrbusNeich Medical Group Holdings's ROIC % is 18.33% (calculated using TTM income statement data). OrbusNeich Medical Group Holdings generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


OrbusNeich Medical Group Holdings  (FRA:Q8T) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, OrbusNeich Medical Group Holdings's WACC % is 8.85%. OrbusNeich Medical Group Holdings's ROIC % is 18.33% (calculated using TTM income statement data). OrbusNeich Medical Group Holdings generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


OrbusNeich Medical Group Holdings ROIC % Related Terms


OrbusNeich Medical Group Holdings ROIC % Historical Data

* Premium members only.

The historical data trend for OrbusNeich Medical Group Holdings's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrbusNeich Medical Group Holdings ROIC % Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROIC %
Get a 7-Day Free Trial 24.56 23.03 29.87 21.84 17.64

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.92 20.49 22.40 16.22 18.97

FRA:Q8T vs ISRG, BDX, MDLN: ROIC % Comparison

For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrbusNeich Medical Group Holdings ROIC % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's ROIC % distribution charts can be found below:

* The bar in red indicates where OrbusNeich Medical Group Holdings's ROIC % falls into.


FRA:Q8T
96GF Score
OrbusNeich Medical Group Holdings Ltd FRA:Q8T
ROIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrbusNeich Medical Group Holdings ROIC % Calculation

OrbusNeich Medical Group Holdings's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROIC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=34.12 * ( 1 - 10.73% )/( (159.21 + 186.032)/ 2 )
=30.458924/172.621
=17.64 %

where

Invested Capital(A: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=386.785 - 13.98 - ( 186.773 - max(0, 28.408 - 299.464+186.773))
=186.032

OrbusNeich Medical Group Holdings's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2025 is calculated as:

ROIC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=40.428 * ( 1 - 15.67% )/( (173.382 + 186.032)/ 2 )
=34.0929324/179.707
=18.97 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=386.785 - 13.98 - ( 186.773 - max(0, 28.408 - 299.464+186.773))
=186.032

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of 18.97% mean?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a ROIC % of 18.97% as of Dec. 2025. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on OrbusNeich Medical Group Holdings and its competitors.
Is OrbusNeich Medical Group Holdings' ROIC % too high?
OrbusNeich Medical Group Holdings' current ROIC % is 18.97%. The Medical Devices & Instruments industry median ROIC % is 1.26. OrbusNeich Medical Group Holdings' value of 18.97% is 1411.6% above this industry median. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' ROIC % compare to ISRG and BDX?
OrbusNeich Medical Group Holdings' ROIC % of 18.97% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROIC % is 1.26. OrbusNeich Medical Group Holdings' value of 18.97% is 1411.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Medical Devices & Instruments company?
The median ROIC % among Medical Devices & Instruments companies is 1.26, based on 846 companies in the industry. Companies in the top quartile (top 25%) have a ROIC % significantly above this median, while those in the bottom quartile fall well below. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrbusNeich Medical Group Holdings's current ROIC % of 18.97% is 1411.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on OrbusNeich Medical Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median ROIC % is 1.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrbusNeich Medical Group Holdings's current ROIC % is 18.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a current ROIC % of 18.97%. The stock's GF Value™ is €0.47, compared to a current price of €0.37 — trading 21.3% below its estimated fair value. The current ROIC % is 18.97% and 1411.6% above the Medical Devices & Instruments industry median of 1.26. OrbusNeich Medical Group Holdings' overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (FRA:Q8T), the current ROIC % is 18.97% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrbusNeich Medical Group Holdings (FRA:Q8T) Overvalued in 2026?

Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued. The current stock price of €0.37 is trading 21.3% below its estimated GF Value™ of €0.47.

Key valuation signals for FRA:Q8T:

  • ROIC %: 18.97%
  • GF Value™: €0.47 vs. price of €0.37 (21.3% below fair value)
  • GF Score™: 96/100 with 2 warning signs
  • Industry Position: 1411.6% above the Medical Devices & Instruments median

No single metric tells the full story. See the FRA:Q8T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OrbusNeich Medical Group Holdings Business Description

Other Exchanges 06929:Hong Kong
Address 3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
96GF Score

Get the complete analysis for FRA:Q8T

ROIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.37
Price
€0.47
GF Value